SOCS3 and diabetic cardiomyopathy: In diabetic cardiomyopathy, DNMT1-mediated methylation of the suppressor of cytokine signaling 3 (SOCS3) promoter suppresses its expression, promoting STAT3 activation and fibrotic remodeling.